Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-007549

EVP, Chief Development Officer acquired 3,874 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Forbes William P EVP, Chief Development Officer 2025-01-19 Option exercise +3,874 106,997 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Forbes William P EVP, Chief Development Officer 2025-01-19 Option exercise · Restricted Stock Units −3,874 46,492 D: show line 2 in the form
Loading xslF345X05/ownership.xml…